Molecular Biologist. CEO of a public Biotech, ORYZON. Wanting to bring cures to needed patients.
Humanist and interested in arts and literature. Living in Barcelona and loving New York, my second home
At ORYZON we develop Firts In Class epigenetic drugs in Oncology and CNS. Our two more advance programs are in Phase II
Our target LSD1 is, intriguingly, opening a door for personalized medicine in psychiatric diseases.
Interested in increase my networking and bonding with the Biotech community.
Invited by: Maria Kelman
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
November 10, 2023 | 58 | 0 | 0.0% |
January 13, 2022 | 58 | +1 | +1.8% |
October 29, 2021 | 57 | +2 | +3.7% |
September 22, 2021 | 55 | +1 | +1.9% |